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Abstract
Metastatic carcinoma cells exploit the same molecular machinery that allows human placental cytotrophoblasts to develop
an invasive phenotype. As altered expression levels of ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin
repeats) subtypes have been associated with cancer progression, we have examined the function and regulation of
members of this gene family in epithelial cell invasion using cultures of highly invasive extravillous cytotrophoblasts and the
poorly invasive JEG-3 cytotrophoblast cell line as model systems. Of the multiple ADAMTS subtypes identified in first
trimester human placenta and these two trophoblastic cell types, only ADAMTS-12 was preferentially expressed by
extravillous cytotrophoblasts. Transforming growth factor-b1 and interleukin-1b, two cytokines that promote and restrain
cytotrophoblast invasion in vitro, were also found to differentially regulate trophoblastic ADAMTS-12 mRNA levels. Loss- or
gain-of-function studies confirmed that ADAMTS-12, independent of its proteolytic activity, plays a specific, non-redundant
role in trophoblast invasion. Furthermore, we demonstrated that ADAMTS-12 regulated cell-extracellular matrix adhesion
and invasion through a mechanism involving the avb3 integrin heterodimer. This study identifies a novel biological role for
ADAMTS-12, and highlights the importance and complexity of its non-proteolytic domain(s) pertaining to its function.
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Introduction
Human placental development and function are dependent
upon mononucleate cytotrophoblasts entering one of two distinct
and mutually exclusive differentiation pathways [1,2]. The villous
pathway culminates in the formation of the syncytial trophoblast, a
multinucleated, terminally differentiated cell that contributes to
the majority of placental transport, immunoregulation and
endocrine functions throughout pregnancy. Alternatively, cytotro-
phoblasts entering the extravillous pathway develop a highly
invasive phenotype, which in turn allows these cells to invade
deeply into the underlying maternal tissues and vasculature,
thereby ensuring a continuous supply of blood to the developing
fetus. Extravillous cytotrophoblast (EVT) invasion, unlike carci-
noma cell metastasis, is a tightly controlled, developmental process
[3,4].
The onset of trophoblastic cell differentiation along the
extravillous pathway is dependent upon the proteolytic degrada-
tion and/or activation of distinct extracellular matrix (ECM)
components, and regulated changes in cell-cell and cell-ECM
interactions [5,6]. Consequently, most studies to date have focused
upon the roles of matrix metalloproteinases/tissue inhibitors of
metalloproteinases (MMPs/TIMPs), cytokines, integrins, and
cadherins in this cellular event. However, there is increasing
evidence to suggest that the regulated expression of members of
the ADAMTS (A Disintegrin And Metalloproteinase with
ThromboSpondin repeats) gene family may represent a significant
molecular mechanism for mediation of the terminal differentiation
of human cytotrophoblasts and the development of an invasive
phenotype.
The ADAMTS are a family of secreted proteins that are
generally characterized by four structural and functional domains;
an amino terminal prodomain, a catalytic domain, a disintegrin-
like domain, and an ECM-binding domain (composed of a central
thrombospondin type 1 (TSP1) motif, a spacer region and a
variable number of TSP-like repeats) at the carboxyl terminal of
the mature protein species [7,8]. Thus, all members of this gene
family have the potential to act as metalloproteinases and to
regulate cell adhesion. Some ADAMTS subtypes have been
further subclassified according to the presence of additional C-
terminal modules or the identification of common substrates.
Furthermore, distinct ADAMTS subtypes have also been shown to
play integral roles in the growth and development of tissues and in
the onset and progression of degradative diseases including cancer
[9–11], arthritis [12], Alzheimer’s disease and a number of
inflammatory and thrombotic conditions [13,14].
Here, we have examined the function and regulation of the
ADAMTS in the differentiation of human cytotrophoblasts along
the extravillous pathway. We first determined that multiple
ADAMTS subtypes are present in first trimester human placenta,
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the poorly invasive JEG-3 choriocarcinoma cell line. Of these, only
ADAMTS-12 was found to be present in EVTs at significantly
higher levels than in JEG-3 cells. The ability of transforming growth
factor (TGF)-b1 and interleukin (IL)-1b, two cytokines assigned
counter-regulatory roles in human placentation [3,15], to differen-
tially regulate ADAMTS-12 mRNA levels in cultures of EVTs
supported our hypothesis that this ADAMTS subtype confers an
invasive phenotype on human trophoblastic cells. Loss- or gain-of-
function studies subsequently confirmed that this ADAMTS
subtype, independent of its intrinsic proteolytic activity, plays an
active and dominant role in human trophoblastic cell invasion in
vitro through a mechanism controlling cell-ECM interaction.
Specifically, ADAMTS-12 modulated cell invasion by regulating
the expression and function of the avb3 integrin heterodimer.
Materials and Methods
Tissues
Samples of first trimester placental tissues were obtained from
women undergoing elective termination of pregnancy (gestational
ages ranging from 6–12 weeks). The use of these tissues was
approved by the Committee for Ethical Review of Research on the
use of human subjects, University of British Columbia. All women
provided informed written consent.
Tissue culture
EVT cultures were propagated from first trimester placental
explants essentially as described [16]. The purity of the EVT
cultures was determined by immunostaining for human cytoker-
atin filaments 8 and 18. Only cultures that exhibited 100%
immunostaining for these cytokeratins were included. 5610
6
EVTs were grown to 80% confluency and treated with TGF-b1
(0.1–10 ng/ml) or IL-1b (1–1000 IU/ml) for 24 h, or TGF-b1
(5 ng/ml) or IL-1b (100 IU/ml) for 0–48 h. EVTs cultured in
vehicle (ethanol) served as controls. Specific cultures were
subjected to a function-perturbing monoclonal antibody against
human TGF-b1 (Sigma Aldrich; 10 mg/ml; clone 9016.2) or IL-1b
(Sigma Aldrich;100 IU/ml; clone 8516.311) for 24 h. JEG-3
trophoblastic cell were purchased from ATCC, Manassas, VA,
USA. On-going cultures were maintained in DMEM containing
25 mM glucose, L-glutamine, antibiotics (100 U/ml penicillin,
100 mg/ml streptomycin) and supplemented with 10% FBS.
Primer Design and preparation of cDNA Probes
Primer sets for ADAMTS-1 through -12 [17] or GAPDH were
synthesized at the NAPS Unit, UBC. The nucleotide sequences of
primers, optimized PCR conditions, and the sizes of the PCR
products are listed in Table S1. To generate cDNA probes for
each ADAMTS or GAPDH, PCR products were generated from
human placental tissue, subcloned into the PCR II vector and
confirmed by nucleotide sequencing. A second set of ADAMTS-
12-specific primers, in which a stretch of nucleotides correspond-
ing to a sequence present within the target ADAMTS-12 PCR
product was incorporated into the 39-end of the forward primer;
These were used for quantitative competitive (QC)-PCR analysis
of ADAMTS-12 mRNA levels in cultures treated with TGF-b1
and IL-1b. This follows a similar approach as reported for
examining urokinase plasminogen activator/plasminogen activa-
tor inhibitor-1 and MMP/TIMP mRNA levels [18].
Semiquantitative PCR and Southern blot analysis
Total RNA was prepared from tissue samples or cells using an
RNeasy Mini Kit (Qiagen, Inc, CA) following the manufacturer
instructions. Aliquots (,1 mg) of the total RNA extracts were then
reverse-transcribed into cDNA using a First Strand cDNA
Synthesis Kit (Amersham Pharmacia Biotech, Oakville, ON,
Canada). Semiquantitative PCR was performed using the primer
sets listed in Table S1. All PCR reactions were performed on 3
separate occasions (n=3). PCR products were separated by
standard electrophoresis followed by Southern blotting according
to the methods of MacCalman et al [19]. The autoradiograms were
scanned using a laser densitometer (Scion Corporation, Frederick,
MD, USA) and the absorbance values of the distinct ADAMTS
PCR products normalized relative to the corresponding GAPDH
value.
QC-PCR
The QC-PCR strategy employed in these studies is based upon
the competitive co-amplification of a known amount of compet-
itive ADAMTS-12 PCR product added to aliquots of first strand
cDNA prepared from our primary cultures of EVTs. The PCR
conditions were: 1 min at 94uC, 1 min at 58.5uC and 1.5 mins at
72uC for 28 cycles followed by a final extension at 72uC for
15 min. The resultant target and competitive ADAMTS-12 PCR
products were separated using gel electrophoresis. PCR products
identity was confirmed by subcloning and DNA sequencing (data
not shown). To determine the optimal amount of competitive
cDNA to be added to each reaction, PCR was performed using
either a fixed amount of template cDNA combined with
decreasing concentrations of competitive cDNA or conversely, a
fixed concentration of competitive cDNA combined with decreas-
ing amounts of template cDNA. The intensity of ethidium
bromide staining of the PCR products was analysed by UV
densitometry, and volume counts determined using the Scion
Image computer software. The competitive ADAMTS-12 cDNA
was subsequently added to each reaction at a concentration of
4.88610
23 pg/ml.
Cell lysis, immunoprecipitation and immunoblot analysis
Cultures of JEG-3 cells or EVTs were washed in PBS and
incubated in cell extraction buffer (Biosource International,
Camarillo, CA) supplemented with 1.0 mM PMSF and Complete
Mini proteinase-inhibitor cocktail (Roche) for 30 minutes. Protein
concentrations were determined using a BCA kit (Pierce
Chemicals, Rockford, IL, USA). Lysates (500 mg) were immuno-
precipitated with an av integrin antibody (Chemicon Internation-
al) overnight at 4uC followed by incubation with protein G plus
protein A agarose beads (Invitrogen) for 1 hr. The precipitated
protein complexes were washed at 4uC in RIPA buffer without
sodium deoxycholate or SDS. For immunoblotting, 30 mg of cell
protein lysate was resolved by SDS-PAGE and transferred to
nitrocellulose membranes. The membranes were probed using
polyclonal antibodies against the carboxyl terminal of human
ADAMTS-12 (Santa Cruz Inc, Santa Cruz, CA, USA) and
ADAMTS-1 (AbCAM), and monoclonal antibodies directed
against av, b1, b3 integrin subunits (Chemicon International),
phospho-397 FAK and FAK (Cell Signaling). The blots were
reprobed with a monoclonal antibody directed against human b-
actin (Sigma Aldrich, St, Louis, MO) to assess protein loading.
siRNA transfection
siRNA (Xeragon Inc, Germantown, MD; 13.5 mg/100 mm
2
culture dish) targeting the human ADAMTS-12 mRNA transcript
(59-AAGCCCGTCCCTCCACCTACA-39) was transfected into
EVTs using TransMessenger transfection reagent (Qiagen)
according to manufacturer’s protocol. EVTs transfected with a
non-silencing, scrambled siRNA (59- ATTTCTCCGAACGTGT-
ADAMTS-12 and Trophoblast Invasion
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alone, served as negative controls. The concentration of siRNAs
used was selected based on previous studies of primary EVT
cultures [20]. Following optimization of the TransMessenger:-
siRNA concentration ratio, all experiments were performed for at
least 24 h.
Expression Vectors
Mammalian expression vectors (pcDNA3.1; Invitrogen, Carls-
bad, CA) containing either a full length human ADAMTS-12
cDNA (pcDNA3-ADAM-TS12-HA) or a full-length human
ADAMTS-12 cDNA in which the catalytic domain had been
inactivated by site directed mutagenesis (pcDNA3-ADAM-TS12-
MUT) were generously provided by Dr. S. Cal (Universidad de
Oviedo, Spain) herein abbreviated as A12FL and A12Mut,
respectively. These constructs have been described [21].
A12Mut cDNA construct has two point mutations in the
metalloproteinase domain, where the thymine (465) and adenine
(466) have been substituted for adenine and cytosine resulting in
the translated protein consisting of a glucine amino acid instead of
histidine thus rendering the protein catalytically inactive. A full-
length human ADAMTS-1 cDNA (Genbank Accession
No. NM006988) was purchased from Origene (Rockville, MD,
USA) and cloned into pcDNA3.1. A clone (A1) containing the
ADAMTS-1 cDNA in the forward orientation was subsequently
identified by DNA sequencing. A pcDNA3.1 expression vector
containing the b-galactosidase gene (pcDNA3-LacZ; Invitrogen)
was used to determine transfection efficiency and served as a
control for these studies.
Generation of stably transfected JEG-3 cell lines
Stable transfections were performed to establish clonal JEG-3
cell lines constitutively expressing A12FL, A12Mut, A1 or LacZ.
Each expression vector (1.0 mg/ml) was transfected using Exgen
500 transfection reagent (Fermentas, Burlington, ON, Canada)
according to the manufacturer’s protocol. Selection began 48 h
post transfection using 400 mg/ml G418 in DMEM, and
subcolonies were isolated by limiting dilution and expanded into
cell lines maintained in the selection medium. At least three
independent clones were selected per construct and protein
expression confirmed by Western blotting (data not shown).
Transwell invasion assays
Cell invasion assays were performed using Transwells fitted with
Millipore Corp. membranes coated with a thin layer of growth
factor-reduced Matrigel (6.5-mm filters, 8-mm pore size) as
described [22]. Briefly, 2610
4 cells/200 ml of DMEM supple-
mented with 1% FBS were plated in the upper chambers and
cultured for 24 h (EVTs) or 48 h (JEG-3 cells). Cells from the
upper surface of the Matrigel layer were removed by gentle
swabbing, while transmigrated cells attached to the membrane
were fixed in 4% paraformaldehyde and stained with eosin. The
filters were rinsed with water, excised from the Transwells, and
mounted upside-down onto glass slides. Invasion indices were
determined by counting the number of stained cells in 10
randomly selected, non-overlapping fields at 4006magnification
using a light microscope. Cell invasion was tested in triplicate
wells, on three independent occasions. A subset of these
experiments were performed in the presence of a synthetic RGD
(Arg-Gly-Asp) or control peptide (1 mM; BIOMOL International,
Plymouth Meeting, PA) following procedures of Buckley et al [23],
a bicyclic RGD peptide (H-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2;
Peptides International) shown to possess high affinity towards avb3
integrin (IC50=0.9 nM) with low affinity for avb5 and aIIBb3
integrins (IC50=10 nM) and a cyclo (Arg-Ala-Asp-D-Phe-cys;
Peptides International) peptide used as a negative control. In
addition to the RGD peptides, a monoclonal function perturbing
av integrin antibody (Chemicon International; mouse anti-integrin
av antibody; clone AV1) was used in Transwell invasion
experiments [24]. Prior to seeding cells into invasion chambers,
5.4610
5 cells in media suspension were pre-incubated in the
presence of the indicated peptide/antibody for 30 min.
Cell aggregation assays
Cell aggregation assays were performed using the cell hanging-
drop method [25]. Briefly, trypsinized single cell suspensions
(1.5610
5 cells/ml) treated with EDTA and passaged through
20 mm nylon sieves were prepared in DMEM media containing
10% FBS. From these suspensions, three 20 ml droplets were
pippetted onto the underside of 6 cm culture dish lids, which were
carefully inverted and placed onto its bottom well containing 2 ml
DMEM media and cultured for 2 or 8 h. After incubation, culture
dish lids were again inverted and glass coverslips were mounted
onto the cell-drop suspensions. The extent of cellular aggregation
was quantified by counting cell aggregates under a light
microscope fitted with a digital camera (2006 magnification);
aggregates were allocated into 3 groups: ,5 cells/aggregate, 5–15
cells/aggregate, and .15 cells/aggregate. Each experiment was
repeated a minimum of three times.
Native ECM-binding assay
Stably transfected JEG-3 cells were plated in 24-wells in
triplicate at high density and allowed to grow to near confluency
for 24 h. Cell media was replaced with fresh DMEM media and
cultured for an additional 48 h to allow for matrix deposition. Cell
monolayers were removed by incubation with 20 mM NH4OH
(265 min) according to Gospodarowicz et al [26] followed by
washing in 16 PBS. JEG-3 cells growing in parallel were
trypsinized, passaged through a 40 mm nylon sieve, plated onto
the ECM deposited by the transfected JEG-3 cell lines and
cultured for 30 min. Cells were washed vigorously in 16PBS, fixed
in 4% paraformaldehyde and stained with eosin. ECM binding
ability was determined by counting the number of cells that had
adhered to the deposited ECM under a microscope.
ECM Cell Adhesion Assay
A fluorimetric ECM cell adhesion array kit (Chemicon
International) allowed us to screen for and quantitate the binding
affinity of cells to 7 different human ECM proteins. Collagen I,
collagen II, collagen IV, fibronectin, laminin, tenascin, and
vitronectin were pre-coated onto 96-well microtiter plates
arranged in 1268-well strips. In each 8-well strip, one BSA-
coated well served as a negative control. Following the
manufacturers instructions, we seeded 1610
5 cells suspended in
DMEM (100 ml) onto the coated ECM-substrates and analysed for
the cells ability to bind to the respective ECM proteins using a
fluorescence plate reader (485/530 nm). The plating of tropho-
blastic cells onto 8-well ECM protein coated strips was performed
on three independent occasions (n=3).
Alpha and Beta Integrin Binding Assay
A fluorimetric a/b Integrin-Mediated Cell Adhesion Array
Combo Kit (Chemicon International) was used to assess the
integrin repertoire expressed on the cell surface. The kit is
comprised of two 96-well plates: an a-integrin binding 96-well
plate and a b-integrin 96-well plate. Each kit uses mouse
monoclonal antibodies generated against human a (a1, a2, a3,
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integrins/subunits, that are immobilized onto goat-anti-mouse
antibody coated microtiter plates. Goat anti-mouse antibody
coated wells served as negative assay controls. Following the
manufacturers protocol, 1610
5 cells suspended in DMEM (100 ml)
were plated into the 96-wells and incubated for 2 h. Unbound cells
were washed away, and adherent cells were lysed and integrin
binding function/expression was detected using a fluorescent
DNA-binding dye provided with the integrin binding kit using a
fluorescence plate reader (485/530 nm). Integrin binding assays
were performed on three independent occasions (n=3).
Statistical Analysis
Statistical differences between the absorbance values were
assessed by the analysis of variance (ANOVA) using GraphPad
Prism 4 computer software (San Diego, CA, USA), and significant
differences between the means were determined using Dunnett’s
test [16]. Cellular invasion indices were analyzed by one-way
ANOVA followed by the Tukey multiple comparison test [22].
The differences were accepted as significant at P,0.05.
Results
Characterization of the ADAMTS subtypes present in
human placental tissue
ADAMTS-1, -2, -4, -5 (also known as ADAMTS-11), -6, -7, -9,
and -12 mRNA levels were detected in first trimester human
placenta (Figure 1A). In contrast, ADAMTS-3, -8 and -10 mRNA
were not detected in these placental tissues but were readily
detectable in our positive controls (data not shown). This
repertoire of ADAMTS subtypes was maintained in both highly
invasive EVTs and poorly invasive JEG-3 cells, with the exception
of ADAMTS-5, which was not detected in either trophoblastic cell
type examined in these studies (Figure 1A). However, ADAMTS-
12 mRNA levels in EVTs were significantly higher than those
detected in JEG-3 cells. In contrast, ADAMTS-1, -2, -7, and -9
mRNA levels were significantly lower in EVTs, whereas there was
no significant difference between the levels of the ADAMTS-4 and
-6 mRNA transcripts present in these two trophoblastic cell types.
High ADAMTS-12 expression is observed in invasive
human trophoblastic cells
As previous work has failed to detect ADAMTS-12 in normal
human tissues and cells [21], we performed Western blot analysis
to confirm that this ADAMTS subtype was expressed in first
trimester human placenta in vivo and in trophoblastic cells in vitro.
Major ADAMTS-12 protein species (83, 50 and 35 kDa),
corresponding to a C-terminal fragments generated by post-
translational cleavage of the ADAMTS-12 zymogen [21] were
detected in the total protein lysates prepared from these placental
tissues or cultures of EVTs or JEG-3 cells (Figure 1B). Further-
more, and in agreement with our PCR data, ADAMTS-12 protein
expression levels were found to be significantly higher in EVTs as
compared to JEG-3 cells.
Cytokines regulate ADAMTS-12 mRNA levels in EVTs
TGF-b1 and IL-1b are spatiotemporally expressed at the
maternal-fetal interface and have been shown to be potent
regulators of human trophoblastic cell invasion in vitro [3,15]. In
view of these observations, we examined the ability of these two
cytokines to regulate ADAMTS-12 mRNA levels in primary
cultures of EVTs in a time- and dose-dependent manner.
ADAMTS-12 mRNA was detected in all of the EVT cultures
(Figures 2A and 2B). The addition of vehicle (ethanol) to the
culture medium of EVTs, which served as a negative control, had
no significant effect on ADAMTS-12 mRNA levels in these cells at
any of the time points examined (data not shown).
A significant decrease in ADAMTS-12 mRNA levels was
detected in EVTs cultured in the presence of TGF-b1 (1 ng/ml)
for 24 h with the levels of this mRNA transcript continuing to
decrease until the termination of these studies at 48 h (Figure 2A).
The addition of increasing concentrations of TGF-b1 to the
culture medium of these cells demonstrated that ADAMTS-12
mRNA levels in EVTs were regulated in a dose-dependent
manner (Figure 2A). A function-perturbing monoclonal antibody
directed against TGF-b1 abolished the TGF-b1-mediated de-
crease in ADAMTS-12 mRNA levels in these primary cell cultures
(Figure 2A). In contrast, IL-1b (100 IU) caused a continuous and
significant increase in ADAMTS-12 mRNA levels in EVTs over
time in culture (Figure 2B). Maximum levels of this mRNA
transcript were subsequently detected in EVTs cultured in the
presence of the highest concentration (1000 IU) of this cytokine
examined in these studies (Figure 2B). A function-perturbing
monoclonal antibody directed against IL-1b was also found to
attenuate the increase in ADAMTS-12 mRNA levels observed in
EVTs cultured in the presence of this cytokine (Figure 2B).
Our initial findings demonstrated that similar to many other
normal and malignant epithelial cells examined to date [21],
ADAMTS-12 expression levels are higher in human trophoblastic
cells with an invasive phenotype. The ability of cytokines to
differentially regulate ADAMTS-12 mRNA levels in primary
cultures of EVTs provided further evidence that ADAMTS-12
contributes to the highly regulated invasion of human trophoblas-
tic cells. In view of these observations, we hypothesized that
altered expression levels of ADAMTS-12 would, in turn, modulate
the invasive capacity of these cells.
Silencing ADAMTS-12 expression reduces the invasive
capacity of EVTs
In order to decrease ADAMTS-12 expression in primary
cultures of EVTs, we obtained 4 distinct siRNA sequences
complementary to the human ADAMTS-12 mRNA transcript.
Transient transfection with these siRNAs demonstrated that only
one siRNA (herein referred to as A12i) significantly decreased
ADAMTS-12 mRNA and protein expression levels in these cell
cultures after 24 h (Figure 3A). In contrast, there was no significant
difference between ADAMTS-12 mRNA and protein levels in the
two control cultures; EVTs transfected with a non-silencing (NS),
scrambled siRNA or cultured in the presence of transfection
reagent alone (EVT; Figure 3A). To verify the knockdown
specificity of A12i and to determine whether there were
compensatory changes in the levels of other ADAMTS subtypes,
PCR was performed using template cDNA generated from EVTs
transfected with either the A12i or control siRNA and the primers
specific for each ADAMTS subtype previously identified in these
cells. Additionally, A12i did not affect the levels of ADAMTS-1, -
2, -4, -6, and -7 mRNA transcripts (Figure 3B). These data
confirm specificity of the siRNA used to knock-down endogenous
ADAMTS-12 mRNA levels in EVT cultures, and also demon-
strate that a reduction in ADAMTS-12 expression is not
accompanied by compensatory changes in the expression of other
ADAMTS subtypes.
We next tested whether a reduction in ADAMTS-12 expression
levels in EVTs would result in a concomitant decrease in their
invasive capacity. Matrigel-coated Transwell invasion chamber
assays revealed that the number of cells that penetrated the
Matrigel barrier and adhered to the underside of the Millipore
ADAMTS-12 and Trophoblast Invasion
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cultures of EVTs transfected with A12i compared to controls
(Figure 3C).
Exogenous ADAMTS-12 induces invasion in JEG-3 cells
To determine whether exogenous ADAMTS-12 expression
could confer an invasive phenotype on trophoblastic cells, JEG-3
cells were stably transfected with the expression vector A12FL; the
catalytic activity of the expressed ADAMTS-12 protein species has
been verified in previous studies derived from the same expression
construct used in this study [21,27]. Similar to our preceding
observations, a major ADAMTS-12 protein species (83 kDa) was
readily detectable in these JEG-3 cells but not in those transfected
with the control LacZ expression vector (Figure 4A). In addition to
Figure 1. Characterization of the ADAMTS subtypes present in human placenta and trophoblastic cells. (A) Representative
autoradiograms of Southern blots containing PCR products synthesized from total RNA from first trimester placenta, JEG-3 cells or EVTs using primers
specific for the indicated ADAMTS or GAPDH. The presented results are densitometry readings showing mean 6 SEM (n$4; *=P#0.05). (B) A
representative Western blot containing total protein prepared from first trimester placenta, EVTs or JEG-3 cells, was probed with a polyclonal
antibody against ADAMTS-12. The blots were re-probed with monoclonal against human b-actin. The molecular weight markers (kDa) are shown to
the left.
doi:10.1371/journal.pone.0018473.g001
ADAMTS-12 and Trophoblast Invasion
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18473the major protein species detected, exogenous expression of
ADAMTS-12 also revealed a minor protein species of approxi-
mately 110 kDa and 50 kDa. Utilizing our transwell invasion
system, we next determined that the invasive capacity of JEG-3 cells
exogenously expressing ADAMTS-12 was significantly and consis-
tently higher than the control cultures (Figure 4A).
Proteinase-dead ADAMTS-12 increases invasion of JEG-3
cells
As a first step in characterizing the molecular mechanisms
underlying ADAMTS-12-mediated cellular invasion, JEG-3 cells
were stably transfected with the mammalian expression vector
containing the proteinase-dead form of ADAMTS-12 (A12Mut)
[21]. Similar to our preceding findings, a major ADAMTS-12
protein species (83 kDa) was readily detectable in these JEG-3 cells
following transfection with this vector (Figure 4A). Furthermore,
Matrigel invasion analysis demonstrated that there was no
significant difference in the invasive capacity of these cells and
those expressing A12FL(3.560.9 (A12Mut) vs. 5.4361.3 (A12FL);
p#0.18), with both cell lines being consistently and significantly
more invasive than the control cultures of JEG-3 cells (Figure 4A).
ADAMTS-1 cannot mimic the effects of ADAMTS-12
induced invasion on JEG-3 cells
To determine whether an increase in the expression levels of
another ADAMTS subtype, other than ADAMTS-12, could
Figure 2. Regulatory effects of TGF-b1 and IL-1b on ADAMTS-12 mRNA expression levels in EVTs. (A) QC-PCR analysis of ADAMTS-12
mRNA levels in EVTs cultured in the presence of (i) TGF-b1 for 0–48 h, (ii) 0–10 ng/ml of TGF-b1 for 24 h, (iii) in the presence of vehicle, TGF-b1 with or
without an antibody against TGF-b1 for 24 h. (B) Similar analyses following (i) 0–48 IL-1b, (ii) 0–1000 IU/ml of IL-1b for 24 h, (iii) in the presence of
vehicle, IL-1b with or without an antibody directed against IL-1b for 24 h. Representative photomicrographs of the resultant ethidium bromide-
stained gels are presented (t and c denote the target and competitive PCR transcripts respectively). The data are presented mean 6 SEM (n=3;
a=P#0.05 vs. untreated control; b=P#0.05 vs. cytokine alone).
doi:10.1371/journal.pone.0018473.g002
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JEG-3 cells were stably transfected with the mammalian
expression vector, pcDNA3-ADAM-TS-1 (A1). Western blot
analysis revealed the presence of two distinct ADAMTS-1 protein
species in these JEG-3 cell cultures and, albeit at lower levels, in
those transfected with the control LacZ vector. These 2 isoforms of
ADAMTS-1 correspond to the zymogen and mature active form
[28]. However, higher ADAMTS-1 expression levels in JEG-3
cells did not result in a concomitant increase in their invasive
capacity (p#0.31; Figure 4B).
Exogenous ADAMTS-12 expression does not affect
cellular aggregation
Cell motility is regulated in part by the differential expression
and function of cell adhesion molecules expressed on the cell
surface [29]. To investigate whether exogenous ADAMTS-12 in
JEG-3 cells could affect cell-cell binding affinity, A12FL, A12Mut,
and LacZ stably transfected JEG-3 cells were subjected to a cell
hanging-drop assay. Figure S1 quantitatively shows that neither
full-length nor proteinase-dead ADAMTS-12 alters the aggrega-
tive capacity of JEG-3 trophoblastic cells assayed at 2 and 8 h
timepoints, suggesting that cell-cell interactions are not modulated
by exogenous ADAMTS-12 expression.
ADAMTS-12 affects cell-ECM affinity in JEG-3 cells
To further elucidate the potential molecular mechanism by
which ADAMTS-12 elicits an invasive phenotype in poorly-
invasive trophoblastic cells, we analyzed whether cell-ECM
binding affinities differed between JEG-3 cells exogenously
expressing full-length ADAMTS-12, proteinase-dead ADAMTS-
12 or LacZ. To do this, we cultured A12FL, A12Mut, and LacZ
transfected JEG-3 cells in a combinatorial fashion on extracellular
matrices deposited by these same JEG-3 transfectants. JEG-3 cells
exogenously expressing ADAMTS-12 significantly adhered more
readily to their own native ECM (Figure 5A). Likewise, JEG-3 cells
exogenously expressing proteinase-dead ADAMTS-12 or LacZ
bound with high affinity to their own ECMs. JEG-3 cells
expressing ADAMTS-12 adhered to ECM deposited by protein-
ase-dead ADAMTS-12 expressing cells and vice versa with high
affinity, whereas control LacZ-expressing cells bound with less
affinity to ECM deposited by A12FL or A12Mut expressing cells.
The ability of the full-length and proteinase-dead ADAMTS-12
expressing JEG-3 cells to bind to ECM deposited by the control
LacZ expressing cells were also significantly ablated. A possible
explanation for the observed differences in cell-ECM binding
could lie in the ability of these cells to differentially synthesize and
deposit specific ECM proteins. To investigate this possibility, we
analyzed by semi-quantitative PCR analysis the mRNA levels of
vitronectin, laminin, tenascin and fibronectin, ECM proteins
known to be expressed in the human endometrium [30–32] and
therefore would be encountered by invading EVTs (Figure S2).
While we did not observe changes in expression levels of these
mRNA transcripts in A12FL and LacZ JEG-3 cells, we did note
strong differences in vitronectin, laminin and tenascin mRNA
levels between primary cultures of EVTs and JEG-3 cells.
Specifically, laminin was expressed in greater levels in JEG-3 cells
than in EVTs, while vitronectin and tenascin were detected
exclusively in EVTs. Taken together, these data suggest that
ADAMTS-12 facilitates cell-matrix interactions by regulating cell-
ECM adhesion through a mechanism(s) independent of its
endogenous proteolytic activity.
RGD peptide disrupts ADAMTS-12 mediated cell-ECM
binding and invasion
In an attempt to elucidate the mechanism by which ADAMTS-
12 regulates cell-ECM binding, we performed native ECM-
binding assays as described above for JEG-3 cells stably transfected
with ADAMTS-12 or LacZ in the presence of a synthetic RGD
Figure 3. Reduced ADAMTS-12 expression levels decrease EVT
invasion. (A) EVTs were transfected with siRNA specific for ADAMTS-12
(A12i), a scrambled control siRNA (NS) or cultured in the presence of
transfection reagent alone (EVT) for 48 h. Cultures were harvested for
total RNA or protein. The results are presented (mean 6 SEM; n$4) in
the bar graphs (*=P#0.05). Representative Western blots prepared
using total protein extracts and probed with antibodies directed against
either ADAMTS-12 or b-actin are shown. The results are presented
(mean 6 SEM; n$4) in the bar graphs (*=P#0.05). (B) Photomicro-
graphs of ethidium bromide stained agarose gels containing PCR
products generated using primers specific for ADAMTS-1, -2, -4, -5, -6, -7
-12 or GAPDH. (C) EVTs were subjected to Matrigel invasion anlaysis as
described in Methods. EVTs cultured in the presence of transfection
reagent alone (EVT) were given an arbitrary invasion index=1.0. Each
cell line was plated in triplicate wells with the experiment repeated on
at least 3 independent occasions (n=3). The results are presented as
mean 6 S.E.M. in the bar graph (*=P#0.05, compared to EVT control).
doi:10.1371/journal.pone.0018473.g003
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peptide treatment significantly abrogated cell-ECM binding in all
ADAMTS-12 and LacZ transfected cell populations, whereas
ECM binding affinities of cells cultured in untreated media or with
the control peptide were not affected (Figure 5B). Interestingly, the
extent of RGD peptide-mediated cell-ECM binding inhibition was
significantly more pronounced in ADAMTS-12 expressing cells
than in LacZ expressing cells cultured on their own native ECM
(p#0.01 versus p#0.05). Similar to our previous findings,
exogenous ADAMTS-12 altered cell-binding affinities to native
ECM deposited by JEG-3 cells transfected with A12FL or LacZ,
though in this experiment it was shown that ADAMTS-12-
mediated cell-ECM adhesion is in part regulated through an
RGD-dependent mechanism. This finding sheds new light on the
putative mechanism by which ADAMTS-12 modulates cell-ECM
interaction, namely through an RGD sequence molecular event
most likely involving members of the integrin cell adhesion
molecule family.
Cell invasion is regulated in part by cell-ECM interactions
mediated primarily through integrin receptors expressed on the
cell surface [33]. Our findings demonstrating that ADAMTS-12
could modulate JEG-3 cell-ECM adhesion in an RGD dependent
manner suggested that ADAMTS-12-mediated cell invasion could
also be regulated through a similar RGD/integrin-dependent
mechanism. To test this hypothesis, we cultured A12FL, A12Mut,
and LacZ expressing JEG-3 cells in Matrigel-coated Transwell
invasion chambers in the presence of the RGD inhibiting peptide.
Cells were also cultured in the presence of a control peptide that
served as a technical control, or were cultured in complete DMEM
media. There were no significant differences in the invasive indices
of LacZ transfected JEG-3 cells when cultured in the presence of
either the RGD or control peptides (Figure 5C). However, the
invasive indices of JEG-3 cells stably transfected with A12FL or
A12Mut cultured in the presence of the RGD peptide were
significantly less than the invasive indices of the same cells cultured
in presence of the control peptide or media alone (Figure 5C).
ADAMTS-12 promotes an invasive EVT-like cell-ECM
binding phenotype
Different integrin heterodimer combinations allow for cells to
acquire distinct ECM substrate preferences, and studies have
shown in both cancer and trophoblast models that specific
integrins regulate cell invasion [34]. Using fluorimetric 96-well
microplate arrays pre-coated with specific ECM proteins (collagen
I, collagen II, collagen IV, fibronectin, laminin, tenascin, and
vitronectin) and monoclonal antibodies to integrin subtypes (a1,
Figure 4. Exogenous ADAMTS-12 expression specifically increases the invasive capacity of JEG-3 cells, independent of its intrinsic
proteolytic activity. (A) A representative Western blot depicting ADAMTS-12 protein levels in JEG-3 cells stably transfected with LacZ, A12FL or
A12Mut. (B) A Western blot depicting ADAMTS-1 protein levels in JEG-3 cells stably transfected with A1 or LacZ. Expression levels of each ADAMTS
were standardized to b-actin. Invasion assays were also performed using these cell lines and are represented as histograms (A and B). The results are
presented as mean 6 S.E.M; n$10 in the bar graphs (*=P#0.05, where * denotes a significantly different value compared to LacZ).
doi:10.1371/journal.pone.0018473.g004
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18473Figure 5. ADAMTS-12 regulates cell-extracellular matrix binding and invasion through an RGD-dependent mechanism. (A) Panels of
photomicrographs of JEG-3 cells stably transfected with A12FL, A12Mut or LacZ. Cells were seeded onto 24-well plates pre-coated with ECM
deposited by the same JEG-3 cell lines in a combinatorial fashion, and cultured for 30 min. Adjacent histograms show the number of cells that had
bound to the pre-deposited native ECM, as described in Methods. (B) JEG-3 cells stably transfected with A12FL or LacZ were subjected to the native
cell-ECM binding experiment described above, however cells were treated with either an RGD inhibiting peptide (RGD; 1 mM), a control peptide
(RGDC; 1 mM) or untreated DMEM media (-). (C) A histogram representing the invasive indices of JEG-3 cells stably transfected with LacZ, A12FL or
A12Mut. Cells were cultured in Matrigel-coated Transwell invasion chambers in complete DMEM media containing the RGD-inhibiting peptide (RGD;
1 mM), control peptide (RGDC; 1 mM) or complete DMEM media without treatment (-). Untreated cell lines were given an arbitrary invasion index of
1, and the invasive capacity of cells cultured in the presence of the control or RGD peptide were determined by generating an invasion index
corresponding to their control cell line. All assays were performed in triplicate and performed on three independent occasions (n=3; *=P#0.05,
compared to controls).
doi:10.1371/journal.pone.0018473.g005
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sought to determine differences in cell-binding affinities to these
defined substrates elicited by ADAMTS-12. Wildtype EVTs
isolated from first trimester chorionic villous explants served as a
biological control for ECM binding affinities associated with an
invasive phenotype. EVTs were shown to bind significantly to all
the ECM proteins analyzed (Figure 6A), however, the binding
affinities to collagen II, fibronectin and vitronectin were strongest.
LacZ expressing JEG-3 cells bound to collagen I, collagen II,
fibronectin, laminin and tensacin, but bound with low affinities to
collagen IV and vitronectin (Figure 6A). Similar to EVTs, A12FL
and A12Mut expressing JEG-3 cells bound significantly to all the
ECM proteins. Notably, their binding affinity to collagen II,
collagen IV and vitronectin were significantly greater than LacZ
expressing cells (Figure 6A). Integrin cell adhesion was also shown
to be different between ADAMTS-12 (A12FL and A12Mut) and
LacZ expressing JEG-3 cells. Whereas EVTs bound with great
affinity to all a integrin subunits (Figure 6B), LacZ-expressing
JEG-3 cells failed to bind to a1, a4, and av antibodies (Figure 6B).
Upon exogenous expression of A12FL or A12Mut, a modest
increase in binding to a3 was observed while binding to the av
antibody was greatly increased as was binding to avb3 (Figure 6B).
Additionally, decreases in binding to the b2 antibody and to avb5
and a5b1 antibodies were observed. Taken together, these data
demonstrate that ADAMTS-12, regardless of a functional catalytic
domain, regulates specific cell-ECM binding differences resem-
bling those of an invasive phenotype.
av integrin expression is controlled by ADAMTS-12
Since studies have shown that the av integrin subunit, and in
particular, the avb3 integrin heterodimer plays an important role in
EVT invasion [34,35] and in light of our findings showing a
significant increase in avb3 mediated cell adhesion (Figure 6), we
investigated whether ADAMTS-12 regulates the expression of these
integrin subunits. In EVTs where endogenous ADAMTS-12 was
knocked down using siRNA, av integrin mRNA and protein levels
showed a correlative decrease in expression compared to controls
(Figure 7A). b1a n db3 integrin subunit levels were unaffected by a
reduction in ADAMTS-12 expression (Figure 7A). Gain of
ADAMTS-12 function in JEG-3 cells (A12FL and A12Mut) lead
to an increase in mRNA and protein expression of the av subunit,
while b1a n db3 integrin subunit protein levels remained
unchanged, although b3 integrin subunit mRNA levels in A12FL
and A12Mut cells showed a modest decrease in expression
(Figure 7B). Since phosphorylation of FAK (phospho-397) is an
indicator of activated integrin signaling [33], we performed Western
blot analysis on protein lysates harvested from EVTs transfected
with ADAMTS-12 siRNA or JEG-3 cells expressing A12FL or
A12Mut and assayed for phospho-397 FAK and total FAK
expression (Figure 7C). Loss-of ADAMTS-12 in EVTs showed a
Figure 6. ADAMTS-12 modulates ECM binding mimicking that of an invasive phenotype. (A) Histogram depicting binding affinities of
EVTs and JEG-3 cells expressing LacZ, A12FL or A12Mut to specific human ECM proteins. A fluorimetric ECM protein binding assay utilizing a 96-well
microtiter plate coated with collagen I, collagen II, collagen IV, fibronectin, laminin, tenascin and vitronectin was used to analyze cell-ECM binding.
Pre-coated BSA served as a negative control. (B) Histograms showing a/b integrin binding affinities of EVTs and LacZ-, A12FL- and A12Mut-expressing
JEG-3 cells. Cell-integrin adhesion was determined in 96-well plates coated with monoclonal antibodies specific to a (a1, a2, a3, a4, a5, av, avb3) or b
(b1, b2, b3, b4, b6, avb5, a5b1) integrins. ECM and integrin adhesion was quantified by lysing bound cells, incubating with the nucleic acid binding
CyQuant GR dye, and reading fluorescence at 485/530 nm. Dotted line provides reference to baseline measurements (n=3; *=P#0.05, where *
denotes a significantly different value compared to LacZ control values).
doi:10.1371/journal.pone.0018473.g006
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of ADAMTS-12 lead to an increase in FAK phosphorylation.
Although total FAK levels in EVTs remained unchanged, we did
observe a proportional increase in total FAK compared to
phosphorylated FAK in JEG-3 cells overexpressing A12FL and
A12Mut. To investigate whether a physical interaction between
ADAMTS-12 and avb3 integrin occurs, we imunoprecipitated av
integrin from protein lysates obtained from A12FL-expressing JEG-
3 cells and probed for ADAMTS-12. IP analysis suggested that no
physicalinteraction betweenADAMTS-12 andavb3 occurs(Figure
S3). Verification of av pull-down was achieved by re-probing the
immunoblot with a monoclonal av-integrin antibody.
ADAMTS-12 controls cell invasion through an avb3
integrin mediated mechanism
Seeing that ADAMTS-12 regulates the expression and function
of avb3 integrin, and that avb3 has been previously shown to
promote an invasive phenotype in human EVTs, we next tested
whether ADAMTS-12-mediated cell invasion is facilitated by
avb3. Treatment of LacZ, A12FL or A12Mut expressing JEG-3
cells with a function-perturbing av integrin antibody cultured in
Matrigel-coated Transwells significantly inhibited A12FL- and
A12Mut-mediated invasion, but had no affect on invasion of LacZ
expressing cells (Figure 8A). In concordance with our previous
data, A12FL and A12Mut showed a significant increase in cell
Figure 7. ADAMTS-12 regulates av integrin expression and FAK activity. (A) Representative ethidium bromide stained agarose gels
containing RT-PCR products (i) and Western blot autoradiographs (ii) respectively depicting mRNA and protein levels of ADAMTS-12, av-, b1-, and b3-
integrin subunits in EVTs untreated (-) or transfected with an siRNA oligonucleotide directed against ADAMTS-12 (A12i) or control non-silencing siRNA
(NS). GAPDH and b-actin serve as endogenous mRNA and protein controls respectively. (B) Ethidium bromide stained gels and Western blot
autoradiographs depicting mRNA (i) and protein levels (ii) of the genes described above in JEG-3 cells stably transfected with pcDNA3.1 constructs
expressing LacZ, A12FL or A12Mut. EVTs served as an ADAMTS-12 positive control. (C) Representative autoradiographs of Western blots depicting
phospho-397 FAK (p397) and total FAK (FAK) protein levels in the EVTs (i) and JEG-3 cells (ii) described above. The molecular weight markers (kDa) are
shown to the left.
doi:10.1371/journal.pone.0018473.g007
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more invasive phenotype over A12Mut. The effect on cell invasion
of a bi-cyclic RGD peptide that demonstrates preference towards
the avb3 integrin heterodimer had a similar affect to that of the av
perturbing antibody (Figure 8B). Specifically, peptide treatment
did not affect LacZ cell invasion, but significantly inhibited A12FL
and A12Mut invasion. Interestingly, the number of avb3 peptide-
treated cells that invaded through the Matrigel-coated insert were
higher in the A12FL population than in the A12Mut population,
suggesting that a component of ADAMTS-12-mediated invasion is
dependent on its catalytic domain. Any advantage that A12Mut
provided in JEG-3 cell invasion was completely abolished with bi-
cyclic RGD peptide treatment.
Discussion
Multiple ADAMTS (ADAMTS-1, -2, -4, -5, -6, -7, -9, and -12)
were detected in tissue samples of first trimester human placenta.
With the exception of ADAMTS-5, this repertoire of ADAMTS
subtypes was maintained, albeit at differing levels, in cultures of
highly invasive EVTs propagated from these tissues and in poorly
invasive JEG-3 cells. Although the overall biological significance of
this expression pattern of ADAMTS proteins in the human
placenta remains to be elucidated, our studies demonstrate that
ADAMTS-12 plays a non-redundant role in human trophoblastic
cell invasion in vitro. In addition, ADAMTS-12 mRNA levels in
EVTs are differentially regulated by TGF-b1 and IL-1b in a
concentration- and time-dependent manner. Thus, ADAMTS-12
is tightly regulated in human trophoblastic cells and signaling
pathways that control invasion act, at least in part, by
downregulating ADAMTS-12 gene expression.
In agreement with our findings, ADAMTS-2 mRNA has been
detected in first trimester placenta [36], with mRNA transcripts
encoding ADAMTS-1, -4, -5, -6, -7, -9, and -10 mRNA also being
found in human term placenta [37–41]. In addition to these
ADAMTS subtypes, we found that ADAMTS-12 is present in
placenta obtained during the first trimester of pregnancy and in
primary cultures of EVTs propagated from these tissues. Cal et al
[21] failed to detect ADAMTS-12 mRNA transcripts in normal
human tissues that included term placenta, but found it exclusively
in fetal lung. Additionally, ADAMTS-12 expression has been
detected in normal cartilage where it is proposed to regulate
chondrocyte differentiation [42]. Differences in placental
ADAMTS-12 mRNA levels are likely attributable to the changes
in the subpopulations of cytotrophoblasts that constitute this
dynamic tissue throughout gestation. In particular, EVTs
predominate during the first trimester with the number of these
cells declining sharply thereafter and being absent in term
placental tissues [1]. Failure to detect ADAMTS-5 in human
trophoblastic cells in vitro suggests that the expression of this
ADAMTS subtype in the placenta is restricted to one or more of
the other cellular compartments that comprise this dynamic tissue,
particularly the mesenchymal core and/or vasculature. Molecular
weight discrepancies between endogenous ADAMTS-12 protein
species in EVTs and first trimester placenta (35 kDa major
product) compared to exogenous ADAMTS-12 in JEG-3 cells
(83 kDa major product) were observed. This could in part be
explained by the different cell types analyzed and variability in
expression of proteolytic processing enzymes. Artificially high
levels of over-expressed ADAMTS-12 may saturate proteolytic
processes resulting in a decrease in these cleavage products.
In contrast to its restricted expression in normal human tissues,
ADAMTS-12 mRNA is readily detectable in the cartilage and
synovium of patients with arthritis and in cancer cell lines of diverse
origin with levels of this mRNA transcript being present at higher
levels in gastric carcinomas compared to matched normal tissue
controls [21]. These later findings suggest a putative role(s) for
ADAMTS-12 in the development of an invasive cellular phenotype,
and indeed our studies revealed that manipulating the function of
thisADAMTSsubtype ascribeda pro-invasive phenotypeinhuman
trophoblastic cells. Altered expression levels of other ADAMTS
subtypes have also been detected in human carcinomas but their
individual contribution(s) to the onset and progression of cancer
remains unclear [7,9,10,43–45]. For example, ADAMTS-1 mRNA
levels have been shown to be either increased [41] or decreased [9]
in breast carcinomas. Higher levels of this ADAMTS subtype have
also been associated with pancreatic and hepatocellular cancer [43]
whereas ADAMTS-1 mRNA levels are unchanged in the onset and
progression of kidney cancer [46] and decreased in lung carcinomas
[41]. Exogenous expression of ADAMTS-1 has been shown to
decrease the experimental metastasis of Chinese hamster ovary cells
[46] but increase the metastatic potential of mammary and lung
cancer cell lines in vivo [47] whereas our study demonstrates that
Figure 8. ADAMTS-12 promotes cell invasion through an avb3
integrin mediated mechanism. (A) A histogram representing the
number of JEG-3 cells stably transfected with LacZ, A12FL or A12Mut
that invaded through Matrigel-coated Transwell invasion chambers.
Cells were cultured in complete DMEM media alone (-) or containing a
function-perturbing antibody against the av integrin subunit (av Abi;
1:50 dilution) for 48 h. (B) A histogram showing the invasiveness of the
aforementioned JEG-3 cells in Matrigel-coated Transwell invasion
chambers. Cells were cultured in complete DMEM media containing
5n Mo fa navb3 integrin-specific bi-cyclic RGD peptide (cyclic RGD),
control peptide (peptide con) or media alone (-) for 48 h. All assays
were performed in triplicate and performed on three independent
occasions (n=3; *=P#0.05, compared to controls).
doi:10.1371/journal.pone.0018473.g008
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capacity of human trophoblastic cells in vitro. A possible explanation
for these contradicting observations involves auto-proteolytic
processing that can account for pro- or anti-metastatic effects
depending on the cleavage site [46]. It is proposed that proteolytic
cleavage of the substrate binding site in ADAMTS-1 impairs
substrate binding and unveils anti-angiogenic TSP-1 motifs.
Recent studies characterizing the role of ADAMTS-12 in tumor
progression demonstrated an anti-tumorigenic role for this subtype
[48]. Llamazares et al showed ADAMTS-12 to inhibit HGF-
mediated scattering of MDCK cells and also prevented bovine
aortic endothelial cells from forming tubules in response to VEGF.
Additionally, subcutaneous injection of SCID mice with the highly
aggressive lung carcinoma A549 cell line over-expressing
ADAMTS-12 repressed tumor growth. More recently, El Hour
et al [49] characterized the role of ADAMTS-12 in regulating
tumorigenesis using a malignant keratinocyte model system in
ADAMTS-12 null mice. Although this study did not specifically
address cell invasion, it did shed light on the importance of how
ADAMTS-12 in the tumor microenvironment inhibits key aspects
of tumorigenesis, such as cell proliferation and angiogenesis. In
lieu of novel data describing ADAMTS-12 as a putative tumor
suppressor gene expressed predominantly in the stroma [49,50],
further studies are required to evaluate the biological and clinical
significance of (dys)regulated expression levels of ADAMTS-12 in
the onset and/or progression of cancer to the later stages of the
disease state, and to delineate the function of this ADAMTS
subtype in processes such as cell migration, invasion, and growth
in other in vivo tumor model systems.
Our demonstration that ADAMTS-12 modulates both cell-
ECM binding and cell invasion through an RGD-dependent
mechanism is an intriguing finding as neither the disintegrin-like
domain, the TSP-repeat domains nor any other domain of any
characterized ADAMTS metalloproteinase contain RGD-like
motifs [8]. It is therefore unlikely that ADAMTS-12 promotes
an invasive phenotype directly through an RGD-dependent
interaction, but rather regulates the function or expression of
proteins capable of controlling RGD-mediated cell-matrix adhe-
sion and cell invasion. Our work demonstrated that ADAMTS-12
regulates cell-ECM binding to specific ECM substrates and cell
attachment facilitated by specific integrin cell adhesion molecules.
Specifically, we showed that ADAMTS-12 expressing trophoblas-
tic cells bind more readily to collagen II, collagen IV and
vitronectin and up-regulate the expression of av and avb3
integrins on their cell surface. Furthermore, this up-regulation is
associated with an increase in integrin signaling activity and cell
invasion. Collagen IV is a basement membrane protein whereas
collagen II is a fibrillar collagen predominantly found in cartilage
connective tissue and interacts predominantly with b1o rb2
integrins [51,52]. While we did not observe any changes in b1o r
b2 integrin-mediated binding in ADAMTS-12 transfected JEG-3
cells, this conflicting finding may be explained by the ability of
EVTs to synthesize the collagen II degrading protease, MMP-13
[53]. Collagen II remodeling by MMP-13 may result in the
uncovering of cryptic integrin-binding sites that may lead to
increased cell-matrix adhesion by integrins other than b1o rb2.
Collagen interactions mediated by other integrins absent in our
microplate integrin adhesion assay may provide additional
explanations as to why we observed increases in cell binding to
collagens II and IV. For example, a10b1 and a11b1 integrins
have been shown to bind to these collagens in vitro [54]. Lastly, the
association of ADAMTS-12 with the ECM might lead to
proteolytic-independent conformational ECM changes that may
also result in uncovering cryptic integrin binding sites.
Vitronectin is an RGD-containing multifunctional protein
found in serum and extracellular matrices, and is secreted by
trophoblastic cells during the first trimester of pregnancy [55,56].
It has been demonstrated that integrin receptors containing RGD
binding motifs (ie. avb3, avb5, a5b1 and aIIbb3) bind to
vitronectin [52]. The avb3 integrin has been shown to play
important roles in promoting both trophoblast and cancer cell
invasion [34,57–61]. Binding of avb3 integrin to its ligands results
in the activation of mitogen-activated protein kinase (MAPK) and
focal adhesion kinase (FAK) [56]. Kabir-Salmani et al [35]
demonstrated that IGF-I-mediated migration of trophoblasts is
avb3 integrin-dependent and is associated with avb3 integrin
heterodimer co-localization with phosphorylated FAK, paxillin
and viniculin at focal adhesions. These data, along with the
findings in our study, provide strong evidence in assigning a key
role for the avb3 integrin in promoting an invasive phenotype in
human trophoblasts. Activation of FAK is facilitated by many b1
and b3-containing integrins and is therefore not a singular avb3
event [62]. Analysis of FAK activation in our cell culture system
should be interpreted only as an indicator for the acquisition of an
invasive phenotype facilitated by ADAMTS-12. In light of these
observations, avb3 integrin appears to play key roles in facilitating
cell invasion processes in both physiological and pathological
contexts. Recent findings that have shown ADAMTS proteinases
to regulate cell motility through Ras-MAPK signaling events by
mechanisms independent of their MMP-like domain support our
findings [63]. Exactly how ADAMTS-12 regulates integrin
expression remains to be elucidated. Our data would suggest that
ADAMTS-12 acts in a cell automomous manner regulating ECM
activity independent of its endogenous proteolytic function,
however more studies are required to fully interrogate the
mechanisms by which ADAMTS-12 regulates av integrin
transcription and function.
In summary, we have determined that ADAMTS-12, indepen-
dent of its proteolytic activity, plays a critical role in human
trophoblastic cell invasion in vitro. This study not only provides an
insight into the molecular mechanism underlying epithelial cell
invasion but also extends our understanding of the cell biology and
complexity of the ADAMTS gene family. Furthermore, the
trophoblastic cell cultures examined in these studies offer an ideal
model to further dissect the contributions of the distinct domains
of ADAMTS-12 in regulating epithelial cell invasion.
Supporting Information
Figure S1 Exogenous ADAMTS-12 does not alter cellular
aggregation. Photomicrographs show JEG-3 cells stably trans-
fected with pcDNA3-ADAM-TS12 (A12FL), pcDNA3-ADAM-
TS12-MUT (A12Mut) or pcDNA3-LacZ (LacZ) that were
cultured in 20 ml hanging drops for 2 or 8 h prior to being
inverted and mounted with a glass cover slip. The histogram
quantitatively describes cellular aggregation assayed at 2 h as
determined by grouping cell aggregates into three categories (,5
cells/aggregate, 5–15 cells/aggregate, .15 cells/aggregate).
Hanging drop assays were done in triplicate and the experiment
was performed on three independent occasions (n=3).
(TIFF)
Figure S2 ADAMTS-12 does not regulate the expression
of a subset of ECM proteins. Ethidium bromide-stained
photographs of RT-PCR products generated using primers
specific to the ECM proteins vitronectin (V), fibronectin (F),
laminin (L) and tenascin (T) and the housekeeping gene GAPDH
from cDNA’s made from (A) JEG-3 cells stably transfected with
ADAMTS-12 (A12FL) or control LacZ or from (B) cDNA’s made
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product standardization between lanes. L; DNA ladder. PCR
reactions were performed on two separate occasions (N=2).
(EPS)
Figure S3 ADAMTS-12 does not associate with the av
integrin. av integrin was immunoprecipitated from protein
lysates of JEG-3 cells stably transfected with LacZ (lanes 1 and 2),
A12FL (lanes 3 and 4) or A12Mut (lanes 5 and 6). Immunopre-
cipitates (IP) were probed for with antibodies directed against
ADAMTS-12 (A) and av integrin (B). Representative autoradio-
graphs from three independent experiments (N=3) as described
for A and B are shown. The molecular weight markers (kDa) are
shown to the left. IB, immunoblot.
(EPS)
Table S1 Names of genes, DNA primer sequences and
PCRconditionsforthe semiquantitative analysis of levels
of mRNA transcripts for ADAMTS, integrin and ECM
genes in human placental tissue and trophoblastic cells.
(DOC)
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